https://www.taxtmi.com/news?id=40367 Imposition of expansive tariffs on imports and announced plans for additional pharmaceutical tariffs constitute the central regulatory action, applying elevated duties to goods from multiple trading partners and triggering trade disruption. The pharmaceutical tariffs are announced but unspecified, offered as leverage to induce supply-chain relocation, while details on legal authority, tariff classifications, procedural rulemaking, transitional arrangements, and enforcement mechanics remain unprovided. en-us Wed, 09 Apr 2025 18:46:03 +0530 Wed, 09 Apr 2025 18:46:03 +0530 TaxTMI RSS Generator https://www.taxtmi.com/news?id=40367 Imposition of expansive tariffs on imports and announced plans for additional pharmaceutical tariffs constitute the central regulatory action, applying elevated duties to goods from multiple trading partners and triggering trade disruption. The pharmaceutical tariffs are announced but unspecified, offered as leverage to induce supply-chain relocation, while details on legal authority, tariff classifications, procedural rulemaking, transitional arrangements, and enforcement mechanics remain unprovided. News - Wed, 09 Apr 2025 18:46:03 +0530 https://www.taxtmi.com/news?id=40367